We are excited to share three new peer-reviewed papers for emerging MS applications.
Glycobiology published research from the team at UC Davis that utilized our innovative MEA Chips to study glycolipids in the human brain. The article is entitled: “Region-specific quantitation of glycosphingolipids in the elderly human brain with Nanoflow MEA Chip Q/ToF mass spectrometry.”
Regeneron published their research on using our M3 emitters for native MS studies of the affinity binding of therapeutic antibodies. The paper was published in the Journal of Pharmaceutical Sciences, entitled: “A target affinity enrichment workflow to characterize critical post-translational modifications within therapeutic antibodies.”
Journal of Proteome Research has published: “High-Throughput Workflow for Detergent-free Cell-Based Proteomic Characterization” by the Cedars-Sinai Medical Center. This work utilized our M3 emitters for high-throughput proteomics.
